Mode Dx’s business model recognizes the need to form strategic partnering and licensing arrangements to optimize revenue streams and shareholder value. Enquiries are welcomed from any company interested in discussing:

Licensing of near patient IP for application refocusing by Mode Dx.

Joint development projects for novel detection of biomarkers.

R&D collaboration; adding functionality to your product.

Out-licensing of product/technology opportunities that align with Mode Dx’s strategic fit.